2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Çö´ëÂ÷, Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ½Ã¹ü»ç¾÷ Âü¿©

¼ÅŬ Ç÷§Æû ±Û·Î¹ú »ç¾÷ È®Àå ±â¹Ý ¸¶·Ã
Çö´ëÂ÷°¡ Çë°¡¸®¿¡¼­ Áö¿ª ±³Åë ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¼ö¿äÀÀ´ä±³Åë(Demand Responsive Transport, DRT) ¿î¿µ ½Ã¹ü»ç¾÷¿¡ Âü¿©ÇÑ´Ù. ±¹³» ¼º°øÀûÀÎ ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º Á¦°ø °æÇèÀ» ¹ÙÅÁÀ¸·Î ±Û·Î¹ú ½ÃÀåÀ¸·Î ¼­ºñ½º È®´ë¸¦ ÃßÁøÇÑ´Ù´Â Á¡¿¡¼­ Àǹ̰¡ ÀÖ´Ù. Çö´ëÀÚµ¿Â÷´Â Áö³­´Þ 31ÀÏ(ÇöÁö½Ã°¢) Çë°¡¸® ±«µÉ·Ú(Gödöllő)½Ã¿¡¼­ ¿­¸° ‘Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º °³Åë½Ä’¿¡¼­ ÃÖ÷´Ü ¼ö¿äÀÀ´ä±³Åë Ç÷§ÆûÀ» Á¦°øÇϰí, ±Û·Î¹ú »ç¾÷ È®Àå ±â¹ÝÀ» ¸¶·ÃÇÑ´Ù°í 3ÀÏ(ÀÏ) ¹àÇû´Ù. °³Åë½Ä¿¡ µû¶ó 8¿ù 18ÀϺÎÅÍ 10¿ù ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
Nike Extends its Athletic Leadership (2020-02-08)
SKÅÚ·¹ÄÞ AI ´©±¸, ¿öÄ¿Èú °´½Ç¼­ ¼Õ´Ô ¸Â´Â´Ù (2018-08-12)
±¹Á¦¾Æ¿¬Çùȸ, ¾Æ¿¬ ¹èÅ͸® ÀÌ´Ï¼ÅÆ¼ºê ¹ßÁ· (2021-03-07)
»ï¼ºÀüÀÚ, ¶óÀÌÇÁ½ºÅ¸ÀÏ TV ¡®´õ ¼¼¸®ÇÁ¡¯ 65Çü (2021-07-19)
Àü±¹ ÀÚÀü°Å±æ Á¾Çվȳ» ½ÃÀÛ (2013-01-04)
Ç®¹«¿ø³ìÁó, Àü Á¦Ç° ģȯ°æ ÆÐŰÁö·Î º¯°æ (2018-12-06)
¼ö¼ÒÂ÷ ¾à 5¸¸´ëºÐ ¼ö¼Ò Ãß°¡ È®º¸ (2020-05-25)
°Ç±¹´ë Á¤º¸Åë½Å´ëÇпø, ½Ã´Ï¾îâ¾÷Çаú ½Å¼³ (2018-11-27)
GS¸®Å×ÀÏ, ±æ¸²¾çÇà°ú »óǰ °øµ¿°³¹ß (2021-07-01)
Microsoft, SES and GRC Showcase Azure Cloud for Remote Missi... (2021-07-01)
VESA, eDP Ç¥ÁØ ¹öÀü 1.5 ¹ßÇ¥ (2021-11-12)
¾Èµ¿½Ã, K-POP ¿Â¶óÀÎ Äܼ­Æ® °³ÃÖÇÏ´Ù (2021-11-12)
Àå¾ÖÀÎÀÏÀÚ¸® ¡®ÀϹÝÇü ÀüÀÏÁ¦¡¯ Âü¿©ÀÚ ¸ðÁý (2021-11-12)
ÇöÀå¿¡¼­ ¿¡³ÊÁö Àü·® Á¶´Þ ù ³ÃÀå½Ã¼³ ¼³Ä¡ (2021-11-12)
¹ÎÁÖÈ­¿îµ¿±â³ä»ç¾÷ȸ, ¹ÚÁ¾Ã¶ ¿­»ç À¯Ç° ¼öʰü¸® (2022-03-26)
GS25, ÆíÀÇÁ¡¿¡¼­µµ ¹ÐŰƮ ¸ÅÃâ 852% Áõ°¡ (2020-05-07)
Çö´ëÂ÷±×·ì, ·Îº¸Æ½½º ½Å»ç¾÷ °³Ã´ º»°ÝÈ­ (2018-10-22)
½ÉÇÃÇ÷¡´Ö, °í´Ü¹é ¼¼Æ÷ ¹è¾çÀ° ÆÄ¿ì´õ ½Äǰ °³¹ß (2023-05-02)
½Å¿¹ À̼º°æ, LAP °¡À»È­º¸¼­ ¸Å·Â ¹ß»ê (2014-08-07)
AGCO Agriculture Foundation Donates to Ukraine Emergency Rel... (2022-03-08)
Çѱ¹ È­Àåǰ ½ÃÀå, 1ÀÎ´ç ¼Òºñ±Ý¾× ¼¼°è 10À§ (2019-11-19)
Çö´ëÂ÷±×·ì-·Ñ½º·ÎÀ̽º, AAM ±âü °³¹ß Çù¾à (2022-07-20)
ÇູÇϰ³, ¹Ý·Áµ¿¹° ¡®ÆêÅýᯠ¼­ºñ½º ·ÐĪ (2018-04-26)
LG CNS, ¸¶À̵¥ÀÌÅÍ Ç÷§Æû »ç¾÷ ½Ãµ¿ (2021-10-07)
Á¤½Å°Ç°­ÀÇ ³¯ ±â³ä ¡®¸¶À½Àձ⡯ Ä·ÆäÀÎ (2021-10-07)
       [ÀÌÀü][1]....[2750][2751][2752][2753][2754][2755][2756][2757][2758]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..